Sarcoidosis is a granulomatous multiorgan disease, thought to result from exposure to yet
unidentified antigens in genetically susceptible individuals. The exaggerated inflammatory …

It is now well established that Th17 lymphocytes associate with myriad immune-mediated
inflammatory diseases. Over the past one and a half decades, a subset of Th17 lymphocytes …

Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), leads to the dysregulation of the immune system …

A characteristic feature of sarcoidosis is a dysregulated immune response to persistent
stimuli, often leading to the formation of non-necrotizing granulomas in various organs …

The management of pulmonary sarcoidosis is a complex interplay of disease characteristics,
the impact of medications, and patient preferences. Foremost, it is important to weigh the risk …

Background Sarcoidosis is a systemic granulomatous disease of unknown etiology primarily
affecting the lungs. Treatment is needed when disease symptoms worsen and organ …

Background Infliximab is currently recommended as a third-line treatment for refractory
sarcoidosis. Data in function of clinical phenotype are currently lacking. We evaluated …

Sarcoidosis and chronic beryllium disease are noninfectious lung diseases that are
characterized by the presence of noncaseating granulomatous inflammation. Chronic …

系统性红斑狼疮(Systemic lupus erythematosus, SLE) 是一种慢性, 累及多系统多器官的,
自身免疫性疾病, 可致重要脏器损害, 诊断不及时或治疗不当可危及患者生命 …

Interstitial lung diseases (ILD) are a heterogeneous group of parenchymal pulmonary
disorders that result from varying degrees of inflammation or fibrosis in the lung interstitium …